Clinical Trial Results:
Dose finding study to investigate efficacy and tolerability of a 6 month oral treatment with selenium in patients with autoimmune thyroiditis:
prospective, controlled parallel group study with Cefasel versus placebo
- double blind, randomised clinical multicentre study of phase II with four treatment groups -
Study title in German (see study protocol):
Dosisfindungsstudie zur Untersuchung der Wirksamkeit und Verträglichkeit einer 6-monatigen oralen Selen-Behandlung bei autoimmuner Thyreoiditis: prospektiver, kontrollierter Parallelvergleich von Cefasel versus Placebo
- doppelblinde, randomisierte, klinische Multizenterstudie der Phase II mit vier Behandlungsgruppen -
Summary
|
|
EudraCT number |
2007-001107-38 |
Trial protocol |
DE |
Global completion date |
18 Apr 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Feb 2020
|
First version publication date |
13 Feb 2020
|
Other versions |
|
Summary report(s) |
SESCHI.26371 Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.